Avid Organics Plans First U.S. Manufacturing Facility with $50 Million Investment
Avid Organics Private Limited announced plans to establish its first manufacturing facility outside India in the United States through its subsidiary, Avid Organics America Inc. The facility, targeted to begin operations in 2028, will produce glycine and glycolic acid in technical and cosmetic grades. The company plans to invest up to US $50 million in U.S. operations through 2035, aiming to enhance local manufacturing capabilities and better serve North American customers. Site finalization is underway, with further details to be announced later.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (60/100). Lens Score 37/100.
Outlets measured: thehindu, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 13 Oct, 10:16 am. Other outlets followed.
- 1